Mr. Yaron Eldad will be appointed as the Chief Financial Officer, or CFO, of Evogene, effective April 1, 2022, and shall replace Ms. Dorit Kreiner, whose departure was extended until March 31, 2022. Mr. Eldad brings extensive financial experience, having filled various CFO positions over the last 25 years in public and private technology and biotechnology companies, including Yamba Group Int. Ltd. from 2011 to 2021, Recoly NV from 2008 to 2010, and e-Sim Ltd. from 1998 to 2007.